| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/03/2002 | CA2445640A1 Peptide analogues of myelin basic protein epitopes in the treatment of experimental autoimmune encephalomyelitis (eae) and multiple sclerosis (ms) |
| 10/03/2002 | CA2443676A1 A novel modulator of non-genomic activity of nuclear receptors (mnar) and uses thereof |
| 10/03/2002 | CA2442797A1 Human secreted proteins |
| 10/03/2002 | CA2442777A1 Human secreted proteins |
| 10/03/2002 | CA2442610A1 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 10/03/2002 | CA2442581A1 Efficient methods for isolating functional g-protein coupled receptors and identifying active effectors and efficient methods to isolate proteins involved in olfaction and efficient methods to isolate and identifying active effectors |
| 10/03/2002 | CA2442579A1 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 10/03/2002 | CA2442325A1 Shellfish protein |
| 10/03/2002 | CA2442318A1 Antibodies against cancer |
| 10/03/2002 | CA2442077A1 Novel nucleic acids and polypeptides |
| 10/03/2002 | CA2442019A1 Sex-specific selection of sperm from transgenic animals |
| 10/03/2002 | CA2441986A1 Methods and products related to fgf dimerization |
| 10/03/2002 | CA2441947A1 Human papilloma virus immunoreactive peptides |
| 10/03/2002 | CA2441938A1 Method of evaluating useful cattle |
| 10/03/2002 | CA2441936A1 Methods and compositions for modulating tumor suppression |
| 10/03/2002 | CA2441809A1 Lipsomal vaccines comprising dilipopetides for modulating t1 and t2 immune responses |
| 10/03/2002 | CA2441808A1 Insect nuclear receptor genes and uses thereof |
| 10/03/2002 | CA2441721A1 Human potassium channel |
| 10/03/2002 | CA2441708A1 Mch1r deficient mice |
| 10/03/2002 | CA2441707A1 Human lanosterol synthase, nucleic acid molecules encoding the same, and uses thereof |
| 10/03/2002 | CA2441706A1 A new essential downstream component of the wingless signalling pathway |
| 10/03/2002 | CA2441704A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 10/03/2002 | CA2441703A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 10/03/2002 | CA2441700A1 Polypeptides and nucleic acids for bolekine |
| 10/03/2002 | CA2441684A1 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof |
| 10/03/2002 | CA2441670A1 Novel nucleic acids and polypeptides |
| 10/03/2002 | CA2441665A1 Polynucleotide encoding a novel immunoglobulin superfamily member, apex4, and variants and splice variants thereof |
| 10/03/2002 | CA2441649A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 10/03/2002 | CA2441580A1 Coagulation factor vii derivatives |
| 10/03/2002 | CA2441551A1 Pathogenic and commensal vaccine antigens |
| 10/03/2002 | CA2441484A1 Molecular conjugates for use in treatment of cancer |
| 10/03/2002 | CA2441413A1 Human secreted proteins |
| 10/03/2002 | CA2441397A1 Human secreted proteins |
| 10/03/2002 | CA2441287A1 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
| 10/03/2002 | CA2441201A1 Thrombin and anhydrothrombin with modified carboxyl groups |
| 10/03/2002 | CA2440582A1 Serum albumin binding moieties |
| 10/03/2002 | CA2439961A1 Human cytokine receptor |
| 10/03/2002 | CA2439678A1 Uses of opg ligand to modulate immune responses |
| 10/03/2002 | CA2439630A1 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 10/03/2002 | CA2439431A1 Streptococcus pneumoniae proteins and nucleic acids |
| 10/03/2002 | CA2439409A1 Inhibitors of glycosaminoglycans |
| 10/03/2002 | CA2439096A1 Culture medium for enhanced heterologous protein expression |
| 10/03/2002 | CA2438206A1 Transporters and ion channels |
| 10/03/2002 | CA2437287A1 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 10/03/2002 | CA2436922A1 Rice-origin high expression polypeptide chain elongation factor promoter and method of using the same |
| 10/03/2002 | CA2436340A1 Histidine-rich glycoprotein |
| 10/03/2002 | CA2436224A1 Cytotoxic factors for modulating cell death |
| 10/03/2002 | CA2436208A1 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
| 10/03/2002 | CA2434119A1 Method of preventing t cell-mediated responses by the use of the major histocompatibility complex class ii analog protein (map protein) from staphylococcus aureus |
| 10/03/2002 | CA2433458A1 Keratinocyte growth factor-2 |
| 10/03/2002 | CA2425862A1 Cd19-specific redirected immune cells |
| 10/03/2002 | CA2406527A1 Novel human stras-like protein and nucleic acids encoding the same |
| 10/02/2002 | EP1245955A1 Cytokine-like peptide |
| 10/02/2002 | EP1245680A1 Gibberellin 2 beta-hydroxylase genes of rice and uses thereof |
| 10/02/2002 | EP1245679A1 Vaccine strains against infection with pathogenic bacteria |
| 10/02/2002 | EP1245678A2 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
| 10/02/2002 | EP1245677A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof |
| 10/02/2002 | EP1245675A1 Cancer cell-specific HLA-F antigen and a diagnostic method of cancer by using thereof |
| 10/02/2002 | EP1245673A2 Efficient genetic suppressor elements |
| 10/02/2002 | EP1245574A1 14691, A human glutamate receptor family member and uses therefor |
| 10/02/2002 | EP1245236A1 Preventives and remedies for chronic hepatitis |
| 10/02/2002 | EP1244916A1 INHIBITION OF $g(b)ARRESTIN MEDIATED EFFECTS PROLONGS AND POTENTIATES OPIOID RECEPTOR-MEDIATED ANALGESIA |
| 10/02/2002 | EP1244807A1 Il-6 like polynucleotide |
| 10/02/2002 | EP1244805A1 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 10/02/2002 | EP1244802A2 Root-specific promoter |
| 10/02/2002 | EP1244799A1 Methods and materials relating to gene expression |
| 10/02/2002 | EP1244797A1 Fusion protein delivery system and uses thereof |
| 10/02/2002 | EP1244796A2 Transduction of recombinases for inducible gene targeting |
| 10/02/2002 | EP1244790A2 Nucleic acids encoding polypeptides having chips activity |
| 10/02/2002 | EP1244789A2 Genes identified as required for proliferation of e. coli |
| 10/02/2002 | EP1244788A2 Mutm orthologue and uses thereof |
| 10/02/2002 | EP1244787A2 Activators of caspases |
| 10/02/2002 | EP1244786A1 Screening method for compounds capable of modularing egr-1-regulated expression |
| 10/02/2002 | EP1244785A1 Mus101 and homologues thereof |
| 10/02/2002 | EP1244784A2 Methods and compositions for inhibiting neoplastic cell growth |
| 10/02/2002 | EP1244783A1 Improving stability of flint through o-linked glycosylation |
| 10/02/2002 | EP1244773A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
| 10/02/2002 | EP1244769A1 Production of peptides by fedbatch cultivation of a microorganism |
| 10/02/2002 | EP1244708A1 Method for treating inflammation |
| 10/02/2002 | EP1244706A2 Method for production of a c1 esterase inhibitor (c1-inh)-containing composition |
| 10/02/2002 | EP1244705A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 10/02/2002 | EP1244704A1 Methods of inhibiting the binding of a cd8+ t cell to a class i mhc employing a modified beta 2 microglobulin |
| 10/02/2002 | EP1244703A1 Novel abcb9 transporter and uses thereof |
| 10/02/2002 | EP1244702A2 A process for isolation of osteopontin from milk |
| 10/02/2002 | EP1244701A1 Transferrin polynucleotides, polypeptides, and antibodies |
| 10/02/2002 | EP1244700A2 Vesicle trafficking proteins |
| 10/02/2002 | EP1244699A2 Educational kit and method using tumor necrosis factor-stimulated gene and protein |
| 10/02/2002 | EP1244698A2 Novel human transporter proteins and polynucleotides encoding the same |
| 10/02/2002 | EP1244697A2 Novel polypeptides and nucleic acids encoding same |
| 10/02/2002 | EP1244695A2 Extracellular matrix and cell adhesion proteins as well as genes encoding them |
| 10/02/2002 | EP1244694A2 Putative human g-protein coupled receptors |
| 10/02/2002 | EP1244693A1 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis |
| 10/02/2002 | EP1244692A2 Compositions and methods for detecting stress-inducible proteins |
| 10/02/2002 | EP1244691A1 Complementary peptide ligands generated from higher eukaryote genome sequences |
| 10/02/2002 | EP1244689A2 Cytokine polypeptides and nucleic acids |
| 10/02/2002 | EP1244688A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 10/02/2002 | EP1244687A2 METHODS FOR PROTECTING AGAINST LETHAL INFECTION WITH i BACILLUS ANTHRACIS /i |
| 10/02/2002 | EP1244686A1 Transforming growth factor alpha hiii |
| 10/02/2002 | EP1244685A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 10/02/2002 | EP1244684A1 Cryptosporidium sporozoite antigens |